Social Security's Falling 2027 COLA Estimate Has a Silver Lining Retirees Should Know About
Earlier this year, one Social Security expert was projecting a 4.7% COLA for 2027.
Venues & MTFs
I Wouldn't Touch This Hydrogen Stock Yet -- Here's the One Number I'm Waiting On
Bloom Energy's product backlog is expanding rapidly, but its services backlog is much larger.
Berkshire Hathaway Roughly Tripled $10,000 in a Decade. Did It Beat the Market?
The same $10,000 in an S&P 500 index fund, with dividends reinvested, grew to about $41,300.
Nebius Stock Surged 200% in Just 1 Year. Is It Still a Buy?
Nebius Group's (NASDAQ: NBIS) stock has surged after the artificial intelligence infrastructure company delivered a blockbuster second quarter.
Sugar Prices Erase Early Gains as Real Strength Spurs Long Liquidation
October NY world sugar #11 (SBV26) is down -0.64 (-3.52%) today, and October London ICE white sugar #5 (SWV26) is down -13.20 (-2.52%).
What Happens When You Invest Just $100 a Month in the S&P 500 for 20 Years?
Over the past 100 years, the S&P 500 has generated an average annual return of around 10%.
Why Elastic Stock Snapped Back Today
Elastic is using artificial intelligence to help its clients make better use of their data.
Stocks Fall as Hawkish Warsh Boosts Fed Rate Hike Chances
The S&P 500 Index ($SPX) (SPY) closed down by -0.25% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -0.02%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.70%. E-mi…
Bill Ackman Just Bought Visa, Mastercard, and S&P Global Stock. Each One Collects a Toll on Somebody Else's Sale.
Pershing Square disclosed new stakes of about $1.1 billion each in Visa, Mastercard, and S&P Global as of June 30.
Falling ICE Inventories Boost Arabica Coffee Prices
December arabica coffee (KCZ26) closed up +3.20 (+1.03%) on Friday, and November ICE robusta coffee (RMX26) closed down -26 (-0.73%).
Affirm Stock: Follow Now and Buy Later or Buy Right Now?
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction"…
Soybeans Rally with the Products on Friday
Soybeans posted 14 to 30 cent gains across most contracts on the Friday session. September was up 51 ¼ cents on the week, as November rallied 48 ½ cents. The cmdtyView national average Cash Bean price…
Oracle's Data Center Spending Is Exploding. Here's the Power Stock That Actually Benefits.
Bloom Energy reported triple-digit revenue and earnings growth in the second quarter.
European Stocks Close Higher Despite Fed Chair's Hawkish Tone At Jackson Hole
(RTTNews) - European stocks closed higher on Friday as investors digested regional economic data and assessed Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole Economic Symposium.
Supply Fears Push Cocoa Prices to 11-Month Highs
December ICE NY cocoa (CCZ26) is up +444 (+7.19%) today, and September ICE London cocoa #7 (CAU26) is up +363 (+8.27%).
Stocks Rally as Fed Chair Warsh Vows to Tackle Inflation
The S&P 500 Index ($SPX) (SPY) is up by +0.37% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.34%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.18%. E-mini S&P futures (ESU26)…
Arabica Coffee Supported by a Slump in ICE Inventories
December arabica coffee (KCZ26) is up +5.60 (+1.81%) today, and November ICE robusta coffee (RMX26) is down -20 (-0.56%).
Up 22% in 2026, Is eBay Stock a Buy Right Now?
With a booming collectibles business and a push into live shopping, eBay (NASDAQ: EBAY) is demonstrating the long-sought innovation investors have been asking for.
FDA Approves Eli Lilly's Mounjaro To Reduce Cardiovascular Risk In Type 2 Diabetes
(RTTNews) - Eli Lilly and Co. (LLY), a pharmaceutical company, announced Friday that the U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) to lower the risk of major adverse card…
WK Crosses Above Average Analyst Target
In recent trading, shares of Workiva Inc (Symbol: WK) have crossed above the average analyst 12-month target price of $117.00, changing hands for $119.98/share. When a stock reaches the target an anal…
Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X?
HubSpot Reaches Analyst Target Price
In recent trading, shares of HubSpot Inc (Symbol: HUBS) have crossed above the average analyst 12-month target price of $426.09, changing hands for $428.75/share. When a stock reaches the target an an…
2 Premier Artificial Intelligence (AI) Stocks That Can Plunge Up to 63%, According to Select Wall Street Analysts
Key PointsAlthough the AI revolution has powered the benchmark S&P 500 to all-time highs, optimism isn't universal among Wall Street analysts.
Gilead's Bixlenvo Gets FDA Approval For Virologically Suppressed Adults With HIV
(RTTNews) - Gilead Sciences, Inc. (GILD) on Thursday announced that the U.S. FDA has approved Bixlenvo (bictegravir 75 mg/lenacapavir 50 mg), a once-daily single tablet regimen for the treatment of HI…